BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 232608)

  • 1. A micromethod for sphingomyelinase assay using a chromogenic artificial substrate. Its use in the diagnosis of Niemann-Pick disease.
    Den Tandt WR; Jaeken J; Leroy JG; Eggermont E
    Acta Paediatr Belg; 1979; 32(4):253-8. PubMed ID: 232608
    [No Abstract]   [Full Text] [Related]  

  • 2. A micromethod for sphingomyelinase assay using a chromogenic artificial substrate: its use in the diagnosis of Niemann-Pick disease.
    Den Tandt WR; Jaeken J; Leroy JG; Eggermont E
    Acta Paediatr Belg; 1979; 32(4):253-8. PubMed ID: 232609
    [No Abstract]   [Full Text] [Related]  

  • 3. A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease.
    Gal AE; Brady RO; Hibbert SR; Pentchev PG
    N Engl J Med; 1975 Sep; 293(13):632-6. PubMed ID: 239343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ultramicrochemical assay for sphingomyelinase: rapid prenatal diagnosis of a fetus at risk for Niemann-Pick disease.
    Mazière JC; Mazière C; Hösli P
    Monogr Hum Genet; 1978; 9():198-201. PubMed ID: 215902
    [No Abstract]   [Full Text] [Related]  

  • 5. [Niemann-Pick disease revealed late by miliary tuberculosis: diagnosis by leukocyte determination of sphingomyelinase deficiency].
    Kofman J; Chevalier JP; Brun J
    Nouv Presse Med; 1978 Dec; 7(45):4147. PubMed ID: 218165
    [No Abstract]   [Full Text] [Related]  

  • 6. Gelastic cataplexy in Niemann-Pick disease group C and related variants without generalized sphingomyelinase deficiency.
    Philippart M; Engel J; Zimmerman EG
    Ann Neurol; 1983 Oct; 14(4):492-3. PubMed ID: 6314876
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and biochemical diagnostics of Niemann-Pick disease.
    Maciejko D; Tylki-Szymańska A
    Klin Padiatr; 1986; 198(2):103-6. PubMed ID: 3009958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the activation of sphingomyelinase activity in Niemann-Pick type A, B, and C fibroblasts: enzymological differentiation of types A and B.
    Poulos A; Ranieri E; Shankaran P; Callahan JW
    Pediatr Res; 1984 Nov; 18(11):1088-93. PubMed ID: 6096798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Niemann-Pick disease by analysis of hair-roots.
    Mazière JC; Mazière C; Hosli P; Polonovski J
    Biomedicine; 1979 Jul; 31(4):104-6. PubMed ID: 226194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Niemann-Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 K.
    Harzer K; Rolfs A; Bauer P; Zschiesche M; Mengel E; Backes J; Kustermann-Kuhn B; Bruchelt G; van Diggelen OP; Mayrhofer H; Krägeloh-Mann I
    Neuropediatrics; 2003 Dec; 34(6):301-6. PubMed ID: 14681755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sphingomyelinase activity in a patient with Niemann-Pick disease].
    Sengers RC; Wevers RA; van Haelst UJ; Smeets HL
    Tijdschr Kindergeneeskd; 1989 Apr; 57(2):70-3. PubMed ID: 2545015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.
    Klar R; Levade T; Gatt S
    Clin Chim Acta; 1988 Sep; 176(3):259-67. PubMed ID: 2846208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis of type A and type B Niemann Pick disease and detection of carriers using leukocytes and a chromogenic analogue of sphingomyelin.
    Gal AE; Brady RO; Barranger JA; Pentchev PG
    Clin Chim Acta; 1980 May; 104(1):129-32. PubMed ID: 7389124
    [No Abstract]   [Full Text] [Related]  

  • 14. Biosynthesis of sphingomyelinase in normal and Niemann-Pick fibroblasts.
    Jobb EA; Callahan JW
    Biochem Cell Biol; 1989; 67(11-12):801-7. PubMed ID: 2559757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niemann-Pick disease: prenatal diagnoses and studies of sphingomyelinase activities.
    Wenger DA; Wharton C; Sattler M; Clark C
    Am J Med Genet; 1978; 2(4):345-56. PubMed ID: 233699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type C Niemann-Pick disease in 2 siblings. Biochemical bases of its diagnosis].
    Pámpols T; Pineda M; Ferreter M; Fernández E
    An Esp Pediatr; 1986 Apr; 24(4):250-6. PubMed ID: 3014938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingomyelinase activities of various human tissues in control subjects and in Niemann-Pick disease - development and evaluation of a microprocedure.
    Vanier MT; Revol A; Fichet M
    Clin Chim Acta; 1980 Oct; 106(3):257-67. PubMed ID: 6251986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of tissue sphingomyelinase isoelectric profile in multiple components is extraction-dependent: evidence for a component defect in Niemann-Pick disease type C is spurious.
    Harzer K; Anzil AP; Schuster I
    J Neurochem; 1977 Dec; 29(6):1155-7. PubMed ID: 202675
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of Niemann-Pick disease using a simple and sensitive fluorimetric assay of sphingomyelinase activity.
    Besley GT
    Clin Chim Acta; 1978 Dec; 90(3):269-78. PubMed ID: 31994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type B Niemann-Pick disease. Clinical aspects].
    Ricca V; Landi M; Calì M; Aimar A; Lala R; Corrias A; Javarone A
    Minerva Pediatr; 1986 Jun; 38(11-12):477-81. PubMed ID: 3736526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.